This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. shed 4.7% to $7.42 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.7% to 17,844.24 and Dow Jones Industrial Average falling 0.2% to 41,218.83.
The stock's fall snapped a three-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 88.0% below its 52-week high of $61.90, which the company achieved on July 31st.
The stock underperformed when compared to some of its competitors, as Vanda Pharmaceuticals Inc. rose 0.4% to $4.59, Fortress Biotech Inc. fell 2.7% to $1.78, and Viking Therapeutics Inc. rose 0.44% to $29.49.
Trading volume totaled 83,617, compared to the 50-day average of 200,610.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 05, 2025 16:32 ET (20:32 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。